Cybin (HELP) Other Working Capital Changes (2021 - 2025)
Cybin (HELP) reported Other Working Capital Changes of $12544.5 for Q1 2025, up 102.8% on a YoY basis from $6185.5 in Q1 2024, and down 99.4% quarter-over-quarter from $2.1 million in Q4 2024.
Cybin (HELP) Other Working Capital Changes (2021 - 2025) Analysis & Trends
Cybin has reported Other Working Capital Changes for 5 years, with the latest figure at $12544.5 in Q1 2025.
- For the quarter ending Q1 2025, Other Working Capital Changes rose 102.8% year-over-year to $12544.5; the trailing twelve-month figure through Mar 2025 stood at -$704046.6 (up 3.55% YoY), and the FY2025 full-year result was -$526570.1, up 28.04% from the prior year.
- Other Working Capital Changes for Q1 2025 stood at $12544.5, down from $2.1 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.1 million in Q4 2024, with the low at -$581515.3 in Q4 2021.
- Historically, Other Working Capital Changes has averaged $464141.5 across 5 years, with a median of $12544.5 in 2025.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes plunged 404.6% — and 2024, when it surged 11116.1%.
- Cybin's Other Working Capital Changes stood at -$581515.3 in 2021, then jumped by 111.53% to $67040.0 in 2022, then tumbled by 404.6% to -$204200.9 in 2023, then soared by 1126.09% to $2.1 million in 2024, then sank by 99.4% to $12544.5 in 2025.
- The last three Other Working Capital Changes figures came in at $12544.5 (Q1 2025), $2.1 million (Q4 2024), and $1.2 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 12,544.50 |
| Mar 31, 2025 | 12,544.50 |
| Dec 31, 2024 | 2.10 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | -447,494.26 |
| Mar 31, 2024 | -447,494.26 |
| Dec 31, 2023 | -204,200.88 |
| Dec 31, 2023 | -204,200.88 |
| Sep 30, 2023 | -64,895.95 |
| Sep 30, 2023 | -64,895.95 |
| Jun 30, 2023 | -13,400.14 |
| Jun 30, 2023 | -13,400.14 |
| Dec 31, 2022 | 67,039.97 |
| Dec 31, 2022 | 67,039.97 |
| Sep 30, 2022 | 1.59 Mn |
| Sep 30, 2022 | 1.59 Mn |